141 related articles for article (PubMed ID: 37061719)
1. Association between prolonged corticosteroids use in COVID-19 and increased mortality in hospitalized patients: a retrospective study with inverse probability of treatment weighting analysis.
Viana MV; Pellegrini JAS; Perez AV; Schwarz P; da Silva D; Teixeira C; Gazzana MB; Rech TH
Crit Care; 2023 Apr; 27(1):143. PubMed ID: 37061719
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
3. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylprednisolone treatment on COVID-19: An inverse probability of treatment weighting analysis.
Porta L; Huang SS; Wei C; Su CH; Hsu WT; Sheng WH; Lee CC
PLoS One; 2022; 17(6):e0266901. PubMed ID: 35714141
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study.
Meng M; Chu Y; Zhang S; Li X; Sha J; Wang P; Cui Y; Han M; Dong X; Sun W; Zhang Z; Deng Y; Wang T; Annane D; Jia S; Chen D
BMC Infect Dis; 2022 Nov; 22(1):891. PubMed ID: 36443688
[TBL] [Abstract][Full Text] [Related]
6. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B
Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study.
Lidou-Renault V; Baudouin E; Courtois-Amiot P; Bianco C; Esnault H; Rouet A; Baque M; Tomeo C; Rainone A; Thietart S; Veber R; Ayache C; Pepin M; Lafuente-Lafuente C; Duron E; Cailleaux PE; Haguenauer D; Lemarié N; Paillaud E; Raynaud-Simon A; Thomas C; Boddaert J; Zerah L; Vallet H
J Gerontol A Biol Sci Med Sci; 2022 Jul; 77(7):1352-1360. PubMed ID: 35395678
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study.
Chen Z; Yin X; Tan X; Wang J; Jiang N; Tian M; Li H; Lu Z; Xiong N; Gong Y
Value Health; 2022 May; 25(5):709-716. PubMed ID: 35219601
[TBL] [Abstract][Full Text] [Related]
10. High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.
Langer-Gould A; Xu S; Myers LC; Chen A; Greene JD; Creekmur B; Bruxvoort K; Adams JL; Liu V; Gould MK
Int J Infect Dis; 2022 Dec; 125():184-191. PubMed ID: 36404464
[TBL] [Abstract][Full Text] [Related]
11. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
12. A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohort.
Comparon C; Boubaya M; Sritharan N; Dournon N; Duchemann B; Tine S; Lopez-Sublet M; Mongin M; Giroux-Leprieur B; Bloch-Queyrat C; Sigaux J; Cohen Y; Bohelay G; Caux F; Bihan H; Le Jeune S; Abad S; Levy V; Dhote R;
Infect Dis (Lond); 2021 Oct; 53(10):779-788. PubMed ID: 34024240
[TBL] [Abstract][Full Text] [Related]
13. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?
Kumar G; Patel D; Hererra M; Jefferies D; Sakhuja A; Meersman M; Dalton D; Nanchal R; Guddati AK
J Med Virol; 2022 Jan; 94(1):372-379. PubMed ID: 34559436
[TBL] [Abstract][Full Text] [Related]
14. Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.
Langer-Gould A; Xu S; Myers LC; Chen A; Greene JD; Creekmur B; Bruxvoort K; Adams JL; Liu V; Gould MK
Int J Infect Dis; 2023 Jan; 126():87-93. PubMed ID: 36403818
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
[TBL] [Abstract][Full Text] [Related]
16. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.
Lafaurie M; Martin-Blondel G; Delobel P; Kamar N; Charpentier S; Sommet A; Moulis G;
BMC Pharmacol Toxicol; 2021 Mar; 22(1):14. PubMed ID: 33706794
[TBL] [Abstract][Full Text] [Related]
17. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients.
Bahl A; Johnson S; Chen NW
Intern Emerg Med; 2021 Sep; 16(6):1593-1603. PubMed ID: 33547620
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corticosteroids on Mortality in Hospitalized COVID-19 Patients Not Receiving Invasive Mechanical Ventilation.
Fusina F; Albani F; Granato E; Meloni A; Rozzini R; Sabatini T; Stellini R; Terragnoli P; Rosano A; Abu Hilal M; Natalini G
Clin Pharmacol Ther; 2021 Jun; 109(6):1660-1667. PubMed ID: 33792037
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
Adir Y; Humbert M; Saliba W
J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.
Zhan Y; Shang J; Gu Y; Huang Q; Xie J
J Med Virol; 2021 Jul; 93(7):4292-4302. PubMed ID: 33666250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
